Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016

Paul Mehta1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USACorrespondence[email protected]
View further author information

Jaime Raymond1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Reshma Punjani1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Theodore Larson1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Wendy Kaye2 McKing Consulting Corporation, Atlanta, GA, USAView further author information

Lorene M. Nelson3 Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USAView further author information

Barbara Topol3 Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USAView further author information

Moon Han1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Oleg Muravov1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Corina Genson1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Bryn Davis1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Kevin Horton1 Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USAView further author information

Your download is now in progress and you may close this window